Synthesis of 2′-β-C-methyl toyocamycin and SANGIVAMYCIN (cas 18417-89-5) analogues as potential HCV inhibitors
-
Add time:09/01/2019 Source:sciencedirect.com
Coupling reaction of 2-β-C-methyl-1,2,3,4-tetra-O-benzoyl-d-ribofuranose with 4-amino-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine, followed by debromination and debenzoylation, gave the 2′-β-C-methyl toyocamycin in high yield. Based on this result, a series of 2′-β-C-methyl-4-substituted toyocamycin and SANGIVAMYCIN (cas 18417-89-5) analogues were synthesized for biological screening as potential inhibitors of HCV RNA replication.
We also recommend Trading Suppliers and Manufacturers of SANGIVAMYCIN (cas 18417-89-5). Pls Click Website Link as below: cas 18417-89-5 suppliers
Prev:ArticleDeciphering Deazapurine Biosynthesis: Pathway for Pyrrolopyrimidine Nucleosides Toyocamycin and SANGIVAMYCIN (cas 18417-89-5)
Next:X-ray crystal structure of SANGIVAMYCIN (cas 18417-89-5), a potent inhibitor of protein kinases) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Antiviral activities of 2′-deoxyribofuranosyl and arabinofuranosyl analogs of SANGIVAMYCIN (cas 18417-89-5) against retro- and DNA viruses09/07/2019
- Effect of SANGIVAMYCIN (cas 18417-89-5) and xylosyladenine on the synthesis and methylation of polysomal ribonucleic acid in Ehrlich ascites cells in vitro09/06/2019
- Comparison between the inhibitory activities of SANGIVAMYCIN (cas 18417-89-5) and thioSANGIVAMYCIN (cas 18417-89-5) on nuclear ribonucleic acid synthesis in L1210 cells in vitro09/05/2019
- Design, synthesis and activity against human cytomegalovirus of non-phosphorylatable analogs of toyocamycin, SANGIVAMYCIN (cas 18417-89-5) and thioSANGIVAMYCIN (cas 18417-89-5)☆09/04/2019
- In vivo and enzymatic conversion of toyocamycin to SANGIVAMYCIN (cas 18417-89-5) by Streptomyces rimosus☆09/03/2019
- X-ray crystal structure of SANGIVAMYCIN (cas 18417-89-5), a potent inhibitor of protein kinases09/02/2019
- ArticleDeciphering Deazapurine Biosynthesis: Pathway for Pyrrolopyrimidine Nucleosides Toyocamycin and SANGIVAMYCIN (cas 18417-89-5)08/31/2019
- SANGIVAMYCIN (cas 18417-89-5) induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells08/30/2019
